학술논문
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
17588359